이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
BioNTech 미래 성장
Future 기준 확인 0/6
BioNTech 의 수익은 연간 6.1% 감소할 것으로 예상되는 반면, 연간 수익은 5.9% 로 증가할 것으로 예상됩니다. 5.9% 연간. EPS는 연간 5.6% 만큼 쇠퇴할 것으로 예상됩니다. 자기자본이익률은 3년 후 -2.5% 로 예상됩니다.
주요 정보
-6.1%
수익 성장률
-5.6%
EPS 성장률
| Biotechs 수익 성장 | 24.6% |
| 매출 성장률 | 5.9% |
| 향후 자기자본 수익률 | -2.5% |
| 애널리스트 커버리지 | Good |
| 마지막 업데이트 | 20 Jun 2024 |
최근 미래 성장 업데이트
Analyst Estimates: Here's What Brokers Think Of BioNTech SE (NASDAQ:BNTX) After Its First-Quarter Report
May 08
BioNTech SE Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 24Recent updates
Improved Revenues Required Before BioNTech SE (NASDAQ:BNTX) Shares Find Their Feet
Jun 16BioNTech: Managements Wants 10 Oncology Drug Approvals By 2030, I'm Skeptical
Jun 13Here's Why BioNTech SE's (NASDAQ:BNTX) CEO May Not Expect A Pay Rise This Year
May 11Analyst Estimates: Here's What Brokers Think Of BioNTech SE (NASDAQ:BNTX) After Its First-Quarter Report
May 08BioNTech Earnings Preview: I Will Stay On The Sidelines
May 03BioNTech (NASDAQ:BNTX) Could Easily Take On More Debt
Apr 22We Think You Can Look Beyond BioNTech's (NASDAQ:BNTX) Lackluster Earnings
Mar 27BioNTech SE Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 24BioNTech's Brew: Mixing COVID Legacy With Oncology Ambitions
Mar 20BioNTech Buys Into Autolus' Cell Therapy Tech - Why I Expect A Full Acquisition In Time
Feb 23BioNTech SE (NASDAQ:BNTX) Shares Could Be 30% Above Their Intrinsic Value Estimate
Feb 09Growth Investors: Industry Analysts Just Upgraded Their BioNTech SE (NASDAQ:BNTX) Revenue Forecasts By 20%
Jan 18Earnings Working Against BioNTech SE's (NASDAQ:BNTX) Share Price
Jan 02BioNTech (NASDAQ:BNTX) Could Easily Take On More Debt
Dec 11Time To Worry? Analysts Are Downgrading Their BioNTech SE (NASDAQ:BNTX) Outlook
Oct 22BioNTech (NASDAQ:BNTX) Has A Rock Solid Balance Sheet
Sep 11Is BioNTech (NASDAQ:BNTX) A Risky Investment?
Jun 13A Look At The Intrinsic Value Of BioNTech SE (NASDAQ:BNTX)
May 23BioNTech SE (NASDAQ:BNTX) Analysts Just Slashed This Year's Estimates
Mar 29These 4 Measures Indicate That BioNTech (NASDAQ:BNTX) Is Using Debt Safely
Mar 05A Look At The Fair Value Of BioNTech SE (NASDAQ:BNTX)
Feb 18Bearish: Analysts Just Cut Their BioNTech SE (NASDAQ:BNTX) Revenue and EPS estimates
Feb 02With EPS Growth And More, BioNTech (NASDAQ:BNTX) Makes An Interesting Case
Jan 26BioNTech SE (NASDAQ:BNTX) Held Back By Insufficient Growth Even After Shares Climb 36%
Nov 19BioNTech (NASDAQ:BNTX) Seems To Use Debt Rather Sparingly
Nov 09CDC advisory panel recommends COVID vaccines for children be included in federal program
Oct 19Do BioNTech's (NASDAQ:BNTX) Earnings Warrant Your Attention?
Oct 18Hong Kong approves BioNTech COVID vaccine for infants
Oct 12EMA starts rolling review of Pfizer/BioNTech's Omicron-subvariant adapted shot for kids
Oct 03수익 및 매출 성장 예측
| 날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 12/31/2026 | 2,782 | -557 | -758 | -744 | 15 |
| 12/31/2025 | 2,740 | -548 | -765 | -401 | 19 |
| 12/31/2024 | 2,745 | -419 | -35 | 344 | 19 |
| 3/31/2024 | 2,730 | 113 | 4,944 | 5,732 | N/A |
| 12/31/2023 | 3,819 | 930 | 4,666 | 5,371 | N/A |
| 9/30/2023 | 6,618 | 2,751 | 4,690 | 5,350 | N/A |
| 6/30/2023 | 9,184 | 4,375 | 8,726 | 9,317 | N/A |
| 3/31/2023 | 12,213 | 6,238 | 8,493 | 8,850 | N/A |
| 12/31/2022 | 17,311 | 9,434 | 13,214 | 13,577 | N/A |
| 9/30/2022 | 18,565 | 10,322 | 12,277 | 12,549 | N/A |
| 6/30/2022 | 21,191 | 11,748 | 9,040 | 9,271 | N/A |
| 3/31/2022 | 23,303 | 12,863 | 5,066 | 5,251 | N/A |
| 12/31/2021 | 18,977 | 10,293 | 736 | 890 | N/A |
| 9/30/2021 | 13,790 | 7,493 | 1,198 | 1,338 | N/A |
| 6/30/2021 | 7,770 | 4,072 | -474 | -355 | N/A |
| 3/31/2021 | 2,503 | 1,197 | -376 | -270 | N/A |
| 12/31/2020 | 482 | 15 | -99 | -13 | N/A |
| 9/30/2020 | 165 | -410 | -382 | -326 | N/A |
| 6/30/2020 | 126 | -230 | -239 | -183 | N/A |
| 3/31/2020 | 110 | -192 | -268 | -222 | N/A |
| 12/31/2019 | 109 | -179 | -270 | -198 | N/A |
| 9/30/2019 | 144 | -122 | -220 | -138 | N/A |
| 6/30/2019 | 136 | -116 | -142 | -75 | N/A |
| 3/31/2019 | 132 | -77 | -136 | -55 | N/A |
| 12/31/2018 | 128 | -48 | -126 | -59 | N/A |
| 12/31/2017 | 62 | -86 | N/A | -53 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: BNTX 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -6.1% ).
수익 vs 시장: BNTX 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -6.1% ).
고성장 수익: BNTX 의 수익은 향후 3년간 감소할 것으로 예상됩니다.
수익 대 시장: BNTX 의 수익(연간 5.9% ) US 시장( 8.7% 보다 느리게 성장할 것으로 예상됩니다. 8.7% 연간).
고성장 수익: BNTX 의 수익(연간 5.9% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: BNTX (는) 3년 내에 수익성이 없을 것으로 예상됩니다.